Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 7Breast Neoplasms 4Sleep Initiation and Maintenance Disorders 3Motor Activity 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Small Cell Lung Carcinoma 1Renal Insufficiency, Chronic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parasomnias 1Palliative Patients 1Neoplasms 1Nausea 1Liver Cirrhosis 1Heart Diseases 1Head and Neck Neoplasms 1Fatigue 1Coronary Artery Disease 1Chronic Pain 1Carcinoma, Hepatocellular 1Anxiety Disorders 1Agnosia 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Breathing Exercises × Clear all
NCT04246970 2025-09-15

PreLiveR-T

Hospital Universitario La Fe

Phase NA Enrolling by invitation
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡